MCK - McKesson Corporation

NYSE - Nasdaq Real Time Price. Currency in USD
162.89
+3.95 (+2.49%)
As of 3:56PM EDT. Market open.
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close158.94
Open158.90
Bid162.17 x 900
Ask162.15 x 800
Day's Range156.58 - 163.25
52 Week Range112.60 - 172.18
Volume1,307,019
Avg. Volume4,551,449
Market Cap26.364B
Beta (5Y Monthly)0.81
PE Ratio (TTM)N/A
EPS (TTM)-4.97
Earnings DateJul 29, 2020 - Aug 03, 2020
Forward Dividend & Yield1.64 (1.03%)
Ex-Dividend DateMay 29, 2020
1y Target Est170.73
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-27% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Thomson Reuters StreetEvents

    Edited Transcript of MCK earnings conference call or presentation 20-May-20 12:00pm GMT

    Q4 2020 McKesson Corp Earnings Call

  • Hedge Funds Piled Into McKesson Corporation (MCK) During The Crash
    Insider Monkey

    Hedge Funds Piled Into McKesson Corporation (MCK) During The Crash

    In this article we will check out the progression of hedge fund sentiment towards McKesson Corporation (NYSE:MCK) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and 20 […]

  • Coronavirus update: Global case tally at 4.9 million as Trump considers travel ban on Brazil after big jump in death toll
    MarketWatch

    Coronavirus update: Global case tally at 4.9 million as Trump considers travel ban on Brazil after big jump in death toll

    The number of global cases of the coronavirus that causes COVID-19 rose to 4.9 million on Wednesday and Brazil suffered its worst fatalities since the start of the outbreak, prompting President Donald Trump to say he may bar entry to flights from Brazil.

  • MarketWatch

    McKesson stock falls after earnings beat, but guidance was below expectations

    Shares of McKesson Corp. dropped 1.8% in premarket trading Wednesday, after the retail pharmacy and health care services company reported fiscal fourth-quarter earnings that beat expectations, but provided a downbeat earnings outlook citing "anticipated headwinds" as a result of the COVID-19 pandemic. The company swung to net income for the quarter to March 31 of $1.02 billion, or $5.85 a share, from a loss of $796 million, or $4.17 a share, in the year ago period. Excluding non-recurring items, adjusted earnings per share came to $4.27, beating the FactSet consensus of $4.10. Revenue rose 12% to $58.54 billion, above the FactSet consensus of $55.57 billion, as price increases for branded drugs and higher volumes from retail national account customers boosted sales at its U.S. pharmaceutical and specialty solutions business. For fiscal 2021, the company expects adjusted EPS of $13.95 to $14.75, below the FactSet consensus of $15.42. McKesson expects 2021 revenue growth of 2% to 4%, while the FactSet revenue consensus of $234.6 billion implies 1.5% growth. The stock has slumped 15.3% over the past three months, while the S&P 500 has lost 13.4%.

  • Benzinga

    McKesson: Q4 Earnings Insights

    Shares of McKesson (NYSE:MCK) fell 6% in pre-market trading after the company reported Q4 results.Quarterly Results Earnings per share increased 15.72% over the past year to $4.27, which beat the estimate of $4.08.Revenue of $58,535,000,000 higher by 11.65% from the same period last year, which beat the estimate of $55,580,000,000.Outlook McKesson said it expects FY21 adjusted EPS of $13.95-$14.75, versus analysts' views of $15.46. Details Of The Call Date: May 20, 2020Time: 08:00 AMView more earnings on MCKET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Finvestor.mckesson.com%2Fevents-and-presentations%2Fdefault.aspx&eventid=2299261&sessionid=1&key=DD18171FFEE5C2B86B39405BD2BE7063®Tag=&sourcepage=registerTechnicals 52-week high: $172.18Company's 52-week low was at $112.60Price action over last quarter: down 4.05%Company Profile McKesson is the largest and most complex of the leading third-party logistics providers. The company is engaged in wholesale pharmaceutical and medical products sourcing, distribution and dispensing, contract manufacturing, and related IT services to acute care hospitals and health systems, independent and chain retail pharmacies in North America, Europe, and Canada. Through acquisition and joint ventures McKesson also runs the fourth- largest pharmacy chain and provides technology and consulting services to manufacturers, pharmacies, physician offices, surgery centers, long-term care facilities, and home healthcare businesses.See more from Benzinga * Recap: Lowe's Companies Q1 Earnings * ShiftPixy: P/E Ratio Insights * P/E Ratio Insights for Arbutus Biopharma(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • McKesson Reports Fiscal 2020 Fourth-Quarter and Full-Year Results
    Business Wire

    McKesson Reports Fiscal 2020 Fourth-Quarter and Full-Year Results

    McKesson Corporation (NYSE:MCK) today reported results for the fourth quarter and fiscal year ended March 31, 2020.

  • ACCESSWIRE

    McKesson Corp. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 20, 2020 / McKesson Corp. (NYSE:MCK) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on May 20, 2020 at 8:00 AM Eastern Time. ...

  • Barrons.com

    Buy Drug Distributors’ Stocks Now, Analyst Says. McKesson and 2 More Potential Winners

    The Covid-19 downturn may be an opportunity for the three big U.S. drug distributors, UBS analyst Kevin Caliende says.

  • McKesson (MCK) Earnings Expected to Grow: Should You Buy?
    Zacks

    McKesson (MCK) Earnings Expected to Grow: Should You Buy?

    McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GuruFocus.com

    Wall Street Ends in the Red on Tuesday

    Caesars Entertainment gains on financial results Continue reading...

  • McKesson Declares Quarterly Dividend April 29, 2020
    Business Wire

    McKesson Declares Quarterly Dividend April 29, 2020

    The Board of Directors of McKesson Corporation (NYSE:MCK) today declared a regular dividend of 41 cents per share of common stock. The dividend will be payable on July 1, 2020, to stockholders of record on June 1, 2020.

  • McKesson Corporation to Announce Fourth Quarter Fiscal 2020 Results on May 20, 2020
    Business Wire

    McKesson Corporation to Announce Fourth Quarter Fiscal 2020 Results on May 20, 2020

    McKesson Corporation (NYSE:MCK) will release its fourth quarter fiscal 2020 financial results before market open on Wednesday, May 20, 2020. The company will host a conference call for investors at 8:00 AM Eastern Time to review its financial results.

  • 5 Stock Picks from the Hedge Fund Manager Who Saw The Pandemic Coming
    Insider Monkey

    5 Stock Picks from the Hedge Fund Manager Who Saw The Pandemic Coming

    The day the S&P 500 Index reached its all-time high Sio Capital’s Michael Castor said the following about the coronavirus threat: “The risk is small but not negligible that coronavirus (COVID-19) will become pandemic. The virus is transmissible during the 14-day incubation period when infected carriers are asymptomatic. This is in contrast to diseases like […]

  • MoneyShow

    Healthy Returns from Healthcare Favorites

    Despite a significant economic downturn and a stock market pullback, a few large-cap companies in the healthcare sector managed to hold onto their positive total returns over the trailing 12-month period, observes Ned Piplovic, income expert and editor of DividendInvestor.

  • Should Value Investors Buy McKesson (MCK) Stock?
    Zacks

    Should Value Investors Buy McKesson (MCK) Stock?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • Moody's

    McKesson Corporation -- Moody's announces completion of a periodic review of ratings of McKesson Corporation

    Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of McKesson Corporation and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

  • MCK vs. COO: Which Stock Is the Better Value Option?
    Zacks

    MCK vs. COO: Which Stock Is the Better Value Option?

    MCK vs. COO: Which Stock Is the Better Value Option?

  • Here's Why You Should Invest in McKesson (MCK) Stock Now
    Zacks

    Here's Why You Should Invest in McKesson (MCK) Stock Now

    McKesson (MCK) continues to gain traction from its multi-year strategic growth initiative and distribution solutions segment.

  • GuruFocus.com

    Wall Street Gains on Monday

    Cal-Maine Foods' third-quarter revenue declines Continue reading...

  • UPS to open Worldport facilities for FEMA's use, intensifies focus on health care services
    American City Business Journals

    UPS to open Worldport facilities for FEMA's use, intensifies focus on health care services

    UPS has provided more insight into its "unprecedented" collaboration with the federal government as it fights against the coronavirus epidemic

  • These indicators suggest a stock-market bottom, but coronavirus fears could send the S&P 500 swooning again
    MarketWatch

    These indicators suggest a stock-market bottom, but coronavirus fears could send the S&P 500 swooning again

    The question investors must now ask themselves is whether or not the market has already hit the bottom of this bear market, or whether investors should prepare themselves for worse to come.

  • Reuters

    White House-led airlift of urgently needed medical supplies arrives in New York

    A planeload of desperately needed medical supplies arrived in New York from China on Sunday, the first in a series of flights over the next 30 days organized by the White House to help fight the coronavirus, a White House official said. A commercial carrier landed at John F. Kennedy airport carrying gloves, gowns and masks for distribution in New York, New Jersey and Connecticut, three hard-hit states battling to care for a crush of coronavirus patients. The airlift is a product of a team led by White House senior adviser Jared Kushner, which formed "Project Airbridge," a partnership between large U.S. healthcare distributors such as McKesson Corp, Cardinal, Owens & Minor, Medline and Henry Schein Inc, and the federal government.

  • The Top Health Care Companies in the World
    Investopedia

    The Top Health Care Companies in the World

    Ranked by trailing 12-month sales as of March 2020, these are the largest health care companies globally.

  • McKesson Announces Bansi Nagji to Step Down as Executive Vice President, Chief Strategy and Business Development Officer
    Business Wire

    McKesson Announces Bansi Nagji to Step Down as Executive Vice President, Chief Strategy and Business Development Officer

    McKesson Corporation (NYSE:MCK) today announced that Bansi Nagji, executive vice president and chief strategy and business development officer, will step down from his role effective March 31, 2020. Mr. Nagji has agreed to continue employment with the company for several weeks to assist with transition activities. McKesson is currently conducting a comprehensive search and expects to name Nagji’s successor within the next few months.

  • Is McKesson (MCK) a Great Value Stock Right Now?
    Zacks

    Is McKesson (MCK) a Great Value Stock Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.